CLR-01

N/A

Report date: 2025/06/11 20:01:15

NME

Base Information

Drug NameCLR-01

Drug Alias Namestructural protein modulators (Clear Therapeutics)Abeta inhibitors (Clear Therapeutics)alpha-synuclein inhibitors (Clear Therapeutics)CLR-02TW-1 +[6]

ClassificationSmall molecules

Mechanisms of ActionSynuclein alpha inhibitorsBeta amyloid A4 protein inhibitorsNeuroprotectants

TargetsSynuclein alphaBeta amyloid A4 protein

Therapy Area/IndicationsBrain Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesUniversity Of California, Los Angeles

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesClear Therapeutics Inc University Of California, Los Angeles

Active IndicationsN/A

Inactive IndicationsBrain Diseases

Other Information

ATC CodeN/A